Results 81 to 90 of about 3,048,991 (107)

Hopantenic Acid: Perspectives for Its Use in Psychiatry

open access: yesConsilium Medicum, 2018
Yu.V. Bykov, R.A. Bekker
exaly   +2 more sources

[Pantogam Activ (D-, L-Hopantenic Acid) in the Treatment of Cognitive and Anxiety Disorders in Patients With Arterial Hypertension].

open access: yesZhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova, 2015
To evaluate the efficacy and safety of D-, L-hopantenic acid (pantogam active) on cognitive and anxiety disorders in patients with arterial hypertension.Autors selected 80 inpatients of a cardiology department with the verified diagnosis of hypertension and comorbid cognitive and anxiety disorders (50 patients in the main group, 30 patients in the ...
Anatoly B. Smulevich, B A Volel
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Hopantenic acid beta-glucoside as a new urinary metabolite of calcium hopantenate in dogs.

Drug Metabolism and Disposition, 1986
The metabolism of calcium hopantenate (HOPA) was studied in beagle dogs. After oral administration of 14C-labeled HOPA, 25.5% of the administered radioactivity was excreted in the urine within 24 hr, mostly in the form of unchanged drug. The only metabolite, accounting for 4.2% of the radioactivity in the urine, was isolated by HPLC. The metabolite was
K, Nakano   +4 more
openaire   +2 more sources

Analytical Studies on the Chiral Separation and Simultaneous Determination of Pantothenic Acid and Hopantenic Acid Enantiomers in Rat Plasma by Gas Chromatography—Mass Fragmentography

Journal of Chromatography B, Biomedical Sciences and Applications, 1991
The chiral separation and simultaneous determination of D- and L-pantothenic acids and D- and L-hopantenic acids in rat plasma using gas chromatography-mass fragmentography are described. The method is based on deproteinization by ion-exchange resin, extraction with ethyl acetate under acidic conditions, and derivatization to form several interesting ...
K Banno
exaly   +3 more sources

Method Development and Validation of an HPLC Assay for the Detection of Hopantenic Acid in Human Plasma and Its Application to a Pharmacokinetic Study on Volunteers

open access: yesActa Chromatographica, 2011
Summary A reliable and sensitive reversed-phase high performance liquid chromatography (RP-HPLC) with ultraviolet (UV) detection method was developed and validated for the quantification of hopantenic acid in human plasma. Hopantenic acid, with protocatechuic acid as the internal standard (IS), was extracted from plasma samples using a liquid-liquid ...
Vera Kosman   +2 more
exaly   +2 more sources

[Neurotropic, Anti-Inflammatory and Antitumor Properties of Hopantenic Acid: A Chemoinformatic Analysis of Its Molecule].

Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova, 2015
Hopantenic acid is a well-known nootropic drug similar in its chemical structure to pantothenic acid (vitamin B5). Neurotropic effects of hopantenic acid act through binding with delta- and kappa opioid receptors, modulation of acetylcholine secretion and relationship with dopamine receptors.
Konstantin Rudakov   +2 more
exaly   +3 more sources

Anxiety and Depressive Disorders in Cardiology Practice. Possibilities of Using D,L-Hopantenic Acid

open access: yesConsilium Medicum, 2018
O.D. Ostroumova   +3 more
exaly   +2 more sources

Abnormal fatty acid metabolism in patients in hopantenate therapy during clinical episodes

Journal of Chromatography B: Biomedical Sciences and Applications, 1991
Calcium 4-(2,4-dihydroxy-3,3-dimethylbutyramido)butyrate hemihydrate (hopantenate), a cerebral metabolic enhancer used in Japan since 1978, is a homologue of pantothenic acid. Using mass spectrometry, we found urinary excretion of 4-hydroxydodecanedioic acid, 4-hydroxytetradecanedioic acid and a series of 2-hydroxydicarboxylic acids (C8-C14), in ...
M, Matsumoto   +4 more
openaire   +2 more sources

[Possible Applications of Rac-Hopantenic Acid in the Treatment of Anxiety and Depressive Disorders in Patients With Chronic Cerebral Ischemia].

Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova, 2016
To evaluate the efficacy and tolerability of rac-hopantenic acid (pantogam activ) in patients with mixed anxiety-depressive disorder and anxiety-depressive disorder with chronic cerebral ischemia.A total of 50 patients were examined (30 patients in the main group, 20 patients in the control one).
Ksenia Zakharova
exaly   +3 more sources

Home - About - Disclaimer - Privacy